Navigation Links
Amylin Pharmaceuticals Reports First Quarter Financial Results
Date:4/18/2011

etreleptin for the treatment of obesity to investigate an antibody-related laboratory finding with metreleptin treatment in two patients who participated in a previously completed clinical study of obesity. The Company, with partner Takeda Pharmaceutical Company Limited, is committed to working closely with clinical investigators, regulators and outside experts to determine the best path forward.

"We are pleased with the CHMP's recent recommendation to approve BYDUREON in Europe. This therapy could offer millions of people living with diabetes the benefits of a GLP-1 receptor agonist in just one dose per week," said Daniel M. Bradbury, president and chief executive officer at Amylin Pharmaceuticals. "In the coming quarters, we will continue to advance other key development programs to address the needs of the patients we serve. This includes submitting our reply to the BYDUREON complete response letter, as well as completing our regulatory application for the use of metreleptin in patients with lipodystrophy."

Financial ResultsNet product sales of $150.8 million for the quarter ended March 31, 2011 include net sales of $128.0 million for BYETTA and $22.8 million for SYMLIN® (pramlintide acetate) injection. This compares to net product sales of $172.3 million, consisting of $149.8 million for BYETTA and $22.5 million for SYMLIN for the same period in 2010.

Revenues under collaborative agreements were $1.9 million for the quarter ended March 31, 2011, unchanged from the same period in 2010, and consist of the amortization of upfront fees received under the Company's collaboration agreement with Takeda.  

Selling, general and administrative expenses decreased to $64.6 million for the quarter ended March 31, 2011 from $73.3 million for the same period in 2010. The decrease reflects reduced expenses associated with BYDUREON pre-launch activities and lower business infrastructure spending resulting from continued efforts to
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
2. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
3. Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
4. Amylin Pharmaceuticals to Present at the 2011 ISI Annual Conference
5. Amylin Pharmaceuticals Reports 2010 Financial Results
6. Amylin Pharmaceuticals to Webcast Year-End Financial Results
7. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
8. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
9. Amylin Pharmaceuticals Reports Third Quarter Financial Results
10. Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference
11. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 ... announced the addition of the  "2015 Strategies ...  report to their offering.  ... five-country report contains 500 pages, 120 tables, ... and potential market entrants identify and evaluate ...
(Date:5/27/2015)... -- Protein purification involves the process of isolating proteins ... properties. The objective of a protein purification process is ... fewest contaminants. The global protein purification and isolation market ... 5% to 6% during the forecast period. This market ... and biotechnological fields, growing need to identify new protein-based ...
(Date:5/27/2015)... 27, 2015 Research ... addition of the  "Asia Pacific Ultrasound Devices ... - 2019)"  company profile to their ... , ,Ultrasound is a type of imaging. ... at body parts and structures inside the ...
Breaking Medicine Technology:European Hemostasis Diagnostic Testing Market Strategies 2015 2Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 2Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 3Asia Pacific Ultrasound Devices Market Report 2015 - Growth, Trends And Forecasts 2014 - 2019 2
(Date:5/28/2015)... May 28, 2015 Aureus Medical Group ... nurse practitioner jobs, has announced that it will participate ... Practitioners’ 2015 National Conference to be held June 9-14, ... offers educational programming, networking opportunities, and exhibits with products ... Advanced Practice division will be available to speak ...
(Date:5/28/2015)... 2015 JJ Mowder-Tinney, PT, PhD, NCS, C/NDT, ... York Physical Therapy Association (NYPTA) by the Delegation at their ... of the NYPTA. At the National level, she was ... Research Committee and an abstract reviewer for the Neurology Section ... a member of the Program committee since 2010 and has ...
(Date:5/27/2015)... May 28, 2015 Cincinnati Veterans Affairs ... Open House May 30 from noon-2p.m. in the auditorium. ... how caregivers can offer full-time assistance to Veterans in ... a comprehensive survey process conducted by the medical center ... as a medical foster home, the caregiver must provide ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Ticket Down is a ... The Chicago Blackhawks are currently in the middle of their ... 3-2 in the series. If the Blackhawks can win tonight ... being played on Saturday, May 30th at the Honda Center in ... the best record in the Western Conference as they won the ...
(Date:5/27/2015)... The BBB Code of Business Practices ... enhance customer trust and confidence in business. The Code ... principles that summarize important elements of creating and maintaining ... business accreditation by BBB. Businesses based in the United ... application procedures will be accredited by BBB. , To ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2
... The Mobile Massage Team ( www.mobilemassageteam.com ), ... corporate wellness programs, promotional events, and special affairs, today ... Penjerdel Employee Benefits and Compensation Association ( www.peba.org ... Downtown, Wednesday, April 22, 2009. Team members will ...
... Foundation Radiology Group (FRG), a ... centers, urgent care centers, and long-term acute care institutions, announced ... initial round of venture funding. Louisville, KY-based ... for young growth companies in the Midwest and South, led ...
... Calif., April 13 Align Technology, Inc. (Nasdaq: ... the motion to dismiss filed by Align on March ... declaratory judgment complaint it filed against Align on February ... April 9, 2009, rather than oppose Align,s motion, which ...
... Are there medical complications related to egg donation? ... inform eligible donors of the health risks versus ... outcomes?Robin von Halle, president of Alternative Reproductive Resources ... recruitment firm, says these are always critical issues ...
... Mass., April 13 Millstone Medical Outsourcing,announced today ... located at 4740 Shelby Drive, Memphis, TN, 38118. ... to the existing space, which brings the total ... purpose of the expansion is,to provide additional capacity ...
... S.C., April 13 At a time when skin ... and melanoma rates in younger,females are on the upswing, ... Society (WDS) will provide free skin cancer,screenings and sun ... 18, 2009, from 9 am-3 pm. Led by board-certified ...
Cached Medicine News:Health News:Foundation Radiology Group Raises $10 Million in Venture Funding Led by Chrysalis Ventures 2Health News:Foundation Radiology Group Raises $10 Million in Venture Funding Led by Chrysalis Ventures 3Health News:Align Technology Announces ClearCorrect's Filing of Notice of Voluntary Dismissal of Complaint 2Health News:Egg Donor Surge Makes Due Diligence Critical: 7 Questions Donors Should Ask 2Health News:Millstone Medical Outsourcing Expands Memphis Facility to Accommodate Growth 2Health News:South Carolina Dermatologists Will Serve Tennis Fans With Free Skin Checks and Sun Safety Tips 2
Direct gonioscopy lens with magnification. The lens rests on the scleral flange creating a corneal vault and leaving the anterior chamber angle undisturbed. Three sizes available....
Shahinian lachrymal cannula, blunt tapered with side port....
Shahinian lacrimal cannula, bullet shaped tip, 0.3 mm side opening, straight....
Button Tip Manipulator, 0.50 mm diameter button tip, angled 45 degrees, 15 mm from tip to bend....
Medicine Products: